Blood type, ABO genetic variants, and ovarian cancer survival.
Blood type A and the A1 allele have been associated with increased ovarian cancer risk. With only two small studies published to date, evidence for an association between ABO blood type and ovarian cancer survival is limited.We conducted a retrospective cohort study of Tumor Registry confirmed ovari...
Main Authors: | Gabriella D Cozzi, Rebecca T Levinson, Hilary Toole, Malcolm-Robert Snyder, Angie Deng, Marta A Crispens, Dineo Khabele, Alicia Beeghly-Fadiel |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2017-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC5407760?pdf=render |
Similar Items
-
Platelets, Thrombocytosis, and Ovarian Cancer Prognosis: Surveying the Landscape of the Literature
by: Demetra H. Hufnagel, et al.
Published: (2020-10-01) -
Differential cyclooxygenase expression levels and survival associations in type I and type II ovarian tumors
by: Alicia Beeghly-Fadiel, et al.
Published: (2018-02-01) -
Expression of p52, a non-canonical NF-kappaB transcription factor, is associated with poor ovarian cancer prognosis
by: Demetra H. Hufnagel, et al.
Published: (2020-09-01) -
Correction: Blood type, ABO genetic variants, and ovarian cancer survival.
by: PLOS ONE Staff
Published: (2017-01-01) -
The therapeutic potential of class I selective histone deacetylase inhibitors in ovarian cancer
by: Dineo eKhabele
Published: (2014-05-01)